Details for New Drug Application (NDA): 202516
✉ Email this page to a colleague
The generic ingredient in TELMISARTAN AND AMLODIPINE is amlodipine besylate; telmisartan. There are fifty drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the amlodipine besylate; telmisartan profile page.
Summary for 202516
Tradename: | TELMISARTAN AND AMLODIPINE |
Applicant: | Mylan |
Ingredient: | amlodipine besylate; telmisartan |
Patents: | 0 |
Suppliers and Packaging for NDA: 202516
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
TELMISARTAN AND AMLODIPINE | amlodipine besylate; telmisartan | TABLET;ORAL | 202516 | ANDA | Mylan Pharmaceuticals Inc. | 0378-1075 | 0378-1075-93 | 30 TABLET in 1 BOTTLE, PLASTIC (0378-1075-93) |
TELMISARTAN AND AMLODIPINE | amlodipine besylate; telmisartan | TABLET;ORAL | 202516 | ANDA | Mylan Pharmaceuticals Inc. | 0378-1076 | 0378-1076-93 | 30 TABLET in 1 BOTTLE, PLASTIC (0378-1076-93) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 5MG BASE;40MG | ||||
Approval Date: | Aug 26, 2014 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 10MG BASE;40MG | ||||
Approval Date: | Aug 26, 2014 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 5MG BASE;80MG | ||||
Approval Date: | Aug 26, 2014 | TE: | AB | RLD: | No |
Complete Access Available with Subscription